Global Breast Cancer Therapeutics Market to Grow at a CAGR of 10.8% During the Period 2024-2032, Driven by Advancements in Treatment Systems

The global breast cancer therapeutics market is likely to be driven by rising incidents of breast cancer and advancements in treatment systems. North America, Asia and Europe are likely to be key markets.

Treatments of breast cancer include chemotherapy, surgery, and therapies such as hormonal, radiation and biological. Targeted drug therapy incorporates drugs that target proteins helping breast cancer cells develop, multiply, and live longer. Targeted drugs kill cancer cells or inhibit growth of cancer cells. Targeted drug therapy may be administered as IV, injection, or a pill. Specific targeted therapy drugs, such as monoclonal antibodies, act in multiple ways to regulate cancer cells; some monoclonal antibodies are also considered immunotherapy as these enhance the immune system.

In fifteen to twenty percent of breast cancers, HER2 (growth-enhancing protein) is produced in excess. Such cancers are called HER2-positive breast cancers and develop and multiply more forcefully than HER2-negative breast cancers. Various medicines have been developed to target the HER2 protein.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

HER2-targeted immunotherapy comprises monoclonal antibodies (that bind to the HER2 protein present on cancer cells) which inhibit cells growth. Examples include Trastuzumab (Herceptin and other brand names); Pertuzumab (Perjeta); combination of trastuzumab, pertuzumab, and hyaluronidase injection (Phesgo); and Margetuximab (Margenza). Antibody-drug conjugates refer to monoclonal antibodies linked to a chemotherapy medication. These include Fam-trastuzumab deruxtecan (Enhertu) and Ado-trastuzumab emtansine (Kadcyla).

HER2 is a protein type called a kinase which generally passes on signals (like directing the cell to grow). Drugs blocking kinases are known as kinase inhibitors, and include Lapatinib (Tykerb), Neratinib (Nerlynx), and Tucatinib (Tukysa).

Key Findings of the Report:

• The global breast cancer therapeutics market is expected to be driven by rising incidence of breast cancer.

• Advancements in treatment systems are likely to drive market growth.

• North America, Asia, and Europe are projected to be key markets.

Market Analysis by Therapy, Cancer Type, Distribution Channel and Region:

• By therapy, the market is segmented into Targeted Therapy (further broken down by type into Abemaciclib, Ado-Trastuzumab Emtansine, Everolimus, Trastuzumab, Ribociclib, Palbociclib, Pertuzumab, and Olaparib), Hormonal Therapy [further broken down by type into Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, and Estrogen Receptor Downregulators (ERDs)], and Chemotherapy (further broken down by type into Taxanes, Anthracyclines, Anti-metabolites, Alkylating Agents, Epothilones, and Immunotherapy).

• By cancer type, the market is classified into Hormone Receptor and HER2+.

• By distribution channel, the market is divided into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others.

• By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.